EPIC Program Annual Data Tables 2003-2004: Table VIII

Table VIII
Twenty Most Frequently Purchased Drugs*
Rank by Number
of Claims
DrugStrengthDrug
Type**
Number
of Claims
EPIC
Payments
Rank by
Payment
Top 20 Totals2,187,235$157,073,626
Percent of Top 20 Drugs to Total Paid Claims20.3%22.6%
1FUROSEMIDE40MGGen177,545$805,548167
2LIPITOR10MGSS169,555$16,417,3213
3FOSAMAX70MGSS157,348$14,976,3764
4PLAVIX75MGSS142,603$24,139,3331
5METOPROLOL TARTRATE50MGGen140,755$749,819184
6HYDROCHLOROTHIAZIDE25MGGen128,494$449,071271
7NORVASC5MGSS128,481$7,740,31312
8FUROSEMIDE20MGGen109,164$445,419273
9ATENOLOL50MGGen104,197$613,536214
10PROTONIX40MGSS99,061$13,430,8138
11LIPITOR20MGSS97,203$14,303,2276
12TOPROL XL50MGSS91,006$2,527,98549
13NORVASC10MGSS87,843$7,033,64214
14CELEBREX200MGSS87,296$11,322,4289
15PREVACID30MGSS85,308$16,651,2812
16ATENOLOL25MGGen80,825$610,992215
17XALATAN0.005%SS76,379$3,557,62133
18NEXIUM40MGSS75,799$14,890,0745
19METFORMIN HCL500MGGen74,716$1,841,52368
20AMBIEN10MGSS73,657$4,567,30425

* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2003-September 30, 2004) as well as the percentage of the totals they represent for the year.

** Drug Type values are Gen='Generic' and SS='Sole Source'.